202 related articles for article (PubMed ID: 38878686)
1. Advance on combination therapy strategies based on biomedical nanotechnology induced ferroptosis for cancer therapeutics.
Chen S; Shi J; Yu D; Dong S
Biomed Pharmacother; 2024 Jul; 176():116904. PubMed ID: 38878686
[TBL] [Abstract][Full Text] [Related]
2. The potential application of nanomaterials for ferroptosis-based cancer therapy.
Li Y; Wei X; Tao F; Deng C; Lv C; Chen C; Cheng Y
Biomed Mater; 2021 Jun; 16(4):. PubMed ID: 34038885
[TBL] [Abstract][Full Text] [Related]
3. Nanotechnology Utilizing Ferroptosis Inducers in Cancer Treatment.
Farzipour S; Zefrei FJ; Bahadorikhalili S; Alvandi M; Salari A; Shaghaghi Z
Anticancer Agents Med Chem; 2024; 24(8):571-589. PubMed ID: 38275050
[TBL] [Abstract][Full Text] [Related]
4. Recent progress in nanotechnology based ferroptotic therapies for clinical applications.
Xu Y; Qin Z; Ma J; Cao W; Zhang P
Eur J Pharmacol; 2020 Aug; 880():173198. PubMed ID: 32473167
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis in cancer therapeutics: a materials chemistry perspective.
Guan Q; Zhou LL; Dong YB
J Mater Chem B; 2021 Nov; 9(43):8906-8936. PubMed ID: 34505861
[TBL] [Abstract][Full Text] [Related]
6. Metal-Organic Framework-Based Nanomedicines for Ferroptotic Cancer Therapy.
Song Y; Xu X; Wang Z; Zhao Y
Adv Healthc Mater; 2024 Apr; 13(11):e2303533. PubMed ID: 38221753
[TBL] [Abstract][Full Text] [Related]
7. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
[TBL] [Abstract][Full Text] [Related]
8. Recent progress on targeting ferroptosis for cancer therapy.
Xu G; Wang H; Li X; Huang R; Luo L
Biochem Pharmacol; 2021 Aug; 190():114584. PubMed ID: 33915157
[TBL] [Abstract][Full Text] [Related]
9. Implications of nanotechnology for the treatment of cancer: Recent advances.
Klochkov SG; Neganova ME; Nikolenko VN; Chen K; Somasundaram SG; Kirkland CE; Aliev G
Semin Cancer Biol; 2021 Feb; 69():190-199. PubMed ID: 31446004
[TBL] [Abstract][Full Text] [Related]
10. pH-sensitive nano-systems for drug delivery in cancer therapy.
Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
[TBL] [Abstract][Full Text] [Related]
11. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
[TBL] [Abstract][Full Text] [Related]
12. Progress and Challenges in Tumor Ferroptosis Treatment Strategies: A Comprehensive Review of Metal Complexes and Nanomedicine.
Su Y; Liu B; Wang B; Chan L; Xiong C; Lu L; Zhang X; Zhan M; He W
Small; 2024 Jun; 20(25):e2310342. PubMed ID: 38221682
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine targets iron metabolism for cancer therapy.
Lin L; Chen H; Zhao R; Zhu M; Nie G
Cancer Sci; 2022 Mar; 113(3):828-837. PubMed ID: 34962017
[TBL] [Abstract][Full Text] [Related]
14. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
15. Advances in Ferroptosis-Inducing Agents by Targeted Delivery System in Cancer Therapy.
Xiang D; Zhou L; Yang R; Yuan F; Xu Y; Yang Y; Qiao Y; Li X
Int J Nanomedicine; 2024; 19():2091-2112. PubMed ID: 38476278
[TBL] [Abstract][Full Text] [Related]
16. Recent progress on nanomedicine-induced ferroptosis for cancer therapy.
Zafar H; Raza F; Ma S; Wei Y; Zhang J; Shen Q
Biomater Sci; 2021 Aug; 9(15):5092-5115. PubMed ID: 34160488
[TBL] [Abstract][Full Text] [Related]
17. Recent Progress in Ferroptosis Inducers for Cancer Therapy.
Liang C; Zhang X; Yang M; Dong X
Adv Mater; 2019 Dec; 31(51):e1904197. PubMed ID: 31595562
[TBL] [Abstract][Full Text] [Related]
18. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy.
Parhi P; Mohanty C; Sahoo SK
Drug Discov Today; 2012 Sep; 17(17-18):1044-52. PubMed ID: 22652342
[TBL] [Abstract][Full Text] [Related]
19. Redox Potential and ROS-Mediated Nanomedicines for Improving Cancer Therapy.
Glass SB; Gonzalez-Fajardo L; Beringhs AO; Lu X
Antioxid Redox Signal; 2019 Feb; 30(5):747-761. PubMed ID: 28990403
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
